Welcome to Our Parkinson's Place

I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible. I have Parkinson's
diseases as well and thought it would be nice to have a place where
updated news is in one place. That is why I began this blog.
I am not responsible for it's contents, I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish. This is for you to read and to always keep an open mind.
Please discuss this with your doctor, should you have any questions, or concerns. Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. Please No advertisers, and No Information about Herbal treatments. Please no advertisements.
This is a free site for all.
Thank you.

Tuesday, March 14, 2017

3-D Images of Mutated Protein Variations May Increase Understanding of Parkinson’s


3-D images of 11 mutant versions of a protein connected with Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS) are helping scientists understand how the mutations changed the structure of the protein and damaged its functioning.
University of Bath researchers studied a protein in the central nervous system known as angiogenin, or ANG. It is believed to have both neuroprotective and regenerative functions, protecting cells in the brain and spinal cord. ANG mutations have been implicated in the development of Parkinson’s and ALS.
The research team, which included cell and structural biologists, used software designed to produce 3-D molecular models to create ANG mutation models.
The images give them another tool for studying how changes in molecular structure impair ANG’s functioning. The mutations are believed to contribute to disease progression in both Parkinson’s and ALS.
In previous studies, the team documented the effects that malfunctioning ANG variations had on embryonic stem cells. The mutations prevented ANG from reaching the cells’ nuclei, impairing the protein’s ability to function, they discovered. In addition, they found less ANG in neurodegenerative diseases such as Parkinson’s and ALS.
“We have extended our structural study to eleven new human ANG PD/ALS variants,” the team wrote. They added that they had also created “detailed molecular features of these variants in comparison with the normal ANG protein, thus progressing from understanding structure to using structure to understanding disease.”
Refining the molecular-mutation structures they created by adding more detail could lead to an even better understanding of the way Parkinson’s and ALS development, the team said.
“We hope that the scientific community can use this new knowledge to help design new drugs that will bind selectively to the defective protein to protect the body from its damaging effects,” Professor K. Ravi Acharya, the study’s senior author, said in a news release. He is a structural biologist in the University of Bath’s Department of Biology & Biochemistry.
The team said it hopes the structures it created will lead to an understanding of “the biological roles for these variants which have been implicated in PD and ALS.”

No comments:

Post a Comment